Author(s): Rajendra Kumar Jangde, Tanveer Khan, Harish Bhardwaj

Email(s): rjangdepy@gmail.com

DOI: 10.52711/0974-360X.2023.00422   

Address: Rajendra Kumar Jangde*, Tanveer Khan, Harish Bhardwaj
University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur (C.G.) India 492010.
*Corresponding Author

Published In:   Volume - 16,      Issue - 5,     Year - 2023


ABSTRACT:
Wounds are physical injuries that result in an opening or break of the skin, the proper healing of wounds is essential for the restoration of disrupted anatomical continuity and disturbed functional status of the skin. Healing is complex and initiated in response to an injury that restores the function and integrity of damaged tissues. Nanostructured lipid carriers (NLCs) for dermal application can provide enhanced skin permeation. Naringenin belongs to the ?avanone class of ?avanoids and is abundantly present in citrus fruits. It has therapeutic interventions as antioxidant, anti-in?ammatory, antidiabetic, and anticancer agents. But some drawbacks include poor solubility, fast metabolism and inadequate bioavailabilityhinder the application of ?avanoids, which can be addressed through increased absorption, solubility and stability.The present study was aimed at formulating naringenin-loaded NLCs for reducing the skin irritation potential, increasing the drug loading capacity and prolonging the duration of action. Naringenin-loaded NLCs were prepared by hot melt microemulsion and hot melt probe sonication methods.The properties of the optimized NLCs such as morphology, size, Zeta potential, stability and Invitro drug release were investigated. Naringenin-loadedNLCs showed a sustained release pattern tested and were found to follow the Higuchi model of drug release. Stability studies indicated that the formulations stored at refrigeration and room temperature showed no noticeable differences in the drug content and release profilesIn vitro, after a period of 4 weeks. The results showed that the irritation potential of Naringenin was reduced, the drug loading was increased and the drug release was prolonged by the incorporationof naringenin into the NLCs.


Cite this article:
Rajendra Kumar Jangde, Tanveer Khan, Harish Bhardwaj. Development and Characterization of Nanostructured Lipid Carrier for Topical delivery of Naringenin. Research Journal of Pharmacy and Technology. 2023; 16(5):2572-6. doi: 10.52711/0974-360X.2023.00422

Cite(Electronic):
Rajendra Kumar Jangde, Tanveer Khan, Harish Bhardwaj. Development and Characterization of Nanostructured Lipid Carrier for Topical delivery of Naringenin. Research Journal of Pharmacy and Technology. 2023; 16(5):2572-6. doi: 10.52711/0974-360X.2023.00422   Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-5-81


REFERENCES:
1.    Dange SM, Kamble MS, Bhalerao KK, Chaudhari PD, Bhosale A V., Nanjwade BK, et al. Formulation and evaluation of VLF nanostructured lipid carriers. J Bionanoscience. 2014;8(2):81–9
2.    Qadir A, Aqil M, Ali A, Warsi MH, Mujeeb M, Ahmad FJ, Ahmad S, Beg S. Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: systematic optimization, dermatokinetic and preclinical evaluation. Journal of Drug Delivery Science and Technology. 2020 Jun 1;57:101775.
3.    Jangde RK, Khute S, Bhardwaj H, Yadav K. Development of Nanoformulations forTargeted Transport of CNS Drugs with Greater Pharmacological Activity via the Nose in tothe Brain. Int. J Drug Dev. Res. 2022; 12(14): 984.
4.    Jangde R, Elhassan GO, Khute S, Singh D, et al. Hesperidin-loaded lipid polymer hybridnanoparticles for topical delivery of bioactive drugs. Pharm. 2022; 15(2):211.
5.    Elmowafy M, Al-Sanea MM. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharmaceutical Journal. 2021 Sep 1;29(9):999-1012.
6.    Pooja Sahu, Rajendra Jangade. An Updated Review on Mechanism of Novel Carrier System for Wound Healing. Research J. Topical and Cosmetic Sci. 10(2): July- Dec. 2019 page 65-78.
7.    Rajendra Kumar Jangde, Rabsanjani, Sulekha Khute. Design and Development of Ciprofloxacin Lipid Polymer Hybrid Nanoparticle by Response Surface Methodology. Research J. Pharm. and Tech. 2020; 13(7): 3249-3256.
8.    Jangde R, Singh D. Preparation and optimization of quercetin-loaded liposomes for wound healing, using response surface methodology. Artificial cells, nanomedicine, and biotechnology. 2016 Feb 17;44(2):635-41.
9.    Kumar RP, Abraham A. PVP-coated naringenin nanoparticles for biomedical applications–In vivo toxicological evaluations. Chemico-biological interactions. 2016 Sep 25;257:110-8.
10.    Bhia M, Motallebi M, Abadi B, Zarepour A, Pereira-Silva M, Saremnejad F, Santos AC, Zarrabi A, Melero A, Jafari SM, Shakibaei M. Naringenin nano-delivery systems and their therapeutic applications. Pharmaceutics. 2021 Feb 23;13(2):291.
11.    Maity S, Mukhopadhyay P, Kundu PP, Chakraborti AS. Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals—An in vitro and in vivo approach. Carbohydrate Polymers. 2017 Aug 15;170:124-32.
12.    Smruthi MR, Nallamuthu I, Singsit D, Anand T. Toxicological evaluation of PLA/PVA-naringenin nanoparticles: In vitro and in vivo studies. OpenNano. 2022 Jul 1;7:100061.
13.    Cordenonsi LM, Sponchiado RM, Bandeira JR, Santos RC, Raffin RP, Schapoval EE. Polymeric nanoparticles loaded naringin and naringenin: effect of solvent, characterization, photodegradation and stability studies. Drug Analytical Research. 2020 Dec 18;4(2):64-71.
14.    Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian journal of pharmaceutical sciences. 2009 Jul;71(4):349.
15.    Garud A, Singh D, Garud N. Solid lipid nanoparticles (SLN): method, characterization and applications. International Current Pharmaceutical Journal. 2012 Oct 3;1(11):384-93.
16.    Garcês A, Amaral MH, Lobo JS, Silva AC. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. European Journal of Pharmaceutical Sciences. 2018 Jan 15;112:159-67.
17.    Jain S, Jain S, Khare P, Gulbake A, Bansal D, Jain SK. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug delivery. 2010 Aug 1;17(6):443-51.
18.    Ridolfi DM, Marcato PD, Justo GZ, Cordi L, Machado D, Durán N. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Colloids and Surfaces B: Biointerfaces. 2012 May 1;93:36-40.
19.    Orgul D, Eroglu H, Hekimoglu S. Formulation and characterization of tissue scaffolds containing simvastatin-loaded nanostructured lipid carriers for the treatment of diabetic wounds. Journal of Drug Delivery Science and Technology. 2017 Oct 1;41:280-92.
20.    Liu M, Wen J, Sharma M. Solid lipid nanoparticles for topical drug delivery: mechanisms, dosage form perspectives, and translational status. Current Pharmaceutical Design. 2020 Aug 1;26(27):3203-17.
21.    Jangde R, Singh D. Compatibility studies of quercetin with pharmaceutical excipients used in the development of novel formulation. Research Journal of Pharmacy and Technology. 2014;7(10):1101-5.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available